Education
About Us
Working with TipRanks
Follow Us
Sotera Health Company (SHC)
:SHC
SHC Stock Chart & Stats
$15.74
-$0.21(-1.56%)
At close: 4:00 PM EST
$15.74
-$0.21(-1.56%)
Day’s Range― - ―
52-Week Range$9.53 - $17.78
Previous CloseN/A
Volume149.43K
Average Volume (3M)2.29M
Market Cap
$4.34B
Enterprise Value$6.49B
Total Cash (Recent Filing)$301.03M
Total Debt (Recent Filing)$2.28B
Price to Earnings (P/E)78.9
Beta1.01
Next Earnings
Mar 03, 2026EPS Estimate
0.24Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.26
Shares Outstanding284,093,930
10 Day Avg. Volume4,559,781
30 Day Avg. Volume2,287,707
Financial Highlights & Ratios
PEG Ratio-7.84
Price to Book (P/B)9.55
Price to Sales (P/S)3.52
P/FCF Ratio85.79
Enterprise Value/Market Cap1.50
Enterprise Value/Revenue5.64
Enterprise Value/Gross Profit10.07
Enterprise Value/Ebitda15.20
Forecast
1Y Price Target
$18.60Price Target Upside18.17% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering6
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Market Share And Outsourcing GainsNormalizing end-market volumes, coupled with cross-selling execution, potential outsourcing & marketshare benefits from new industry regulations, support confidence in SHC's growth potential.
Revenue And EBITDA GrowthThe macro/industry headwinds that have dragged on SHC's growth over the last 2–3 years have finally begun to dissipate, clearing the way for a re-acceleration in both revenue and EBITDA growth back toward management's longer-range targets.
Valuation UpsideShares currently trade at a meaningful discount to its peer average, leaving room for some valuation upside as growth continues to recover.
Bears Say
Litigation RiskOngoing litigation remains a risk, but is considered to be sufficiently discounted into the current valuation.
Sotera Health News
SHC FAQ
What was Sotera Health Company’s price range in the past 12 months?
Sotera Health Company lowest stock price was $9.53 and its highest was $17.78 in the past 12 months.
What is Sotera Health Company’s market cap?
Sotera Health Company’s market cap is $4.34B.
When is Sotera Health Company’s upcoming earnings report date?
Sotera Health Company’s upcoming earnings report date is Mar 03, 2026 which is in 87 days.
How were Sotera Health Company’s earnings last quarter?
Sotera Health Company released its earnings results on Nov 04, 2025. The company reported $0.26 earnings per share for the quarter, beating the consensus estimate of $0.218 by $0.042.
Is Sotera Health Company overvalued?
According to Wall Street analysts Sotera Health Company’s price is currently Undervalued.
Does Sotera Health Company pay dividends?
Sotera Health Company does not currently pay dividends.
What is Sotera Health Company’s EPS estimate?
Sotera Health Company’s EPS estimate is 0.24.
How many shares outstanding does Sotera Health Company have?
Sotera Health Company has 284,093,930 shares outstanding.
What happened to Sotera Health Company’s price movement after its last earnings report?
Sotera Health Company reported an EPS of $0.26 in its last earnings report, beating expectations of $0.218. Following the earnings report the stock price went down -1.084%.
Which hedge fund is a major shareholder of Sotera Health Company?
Currently, no hedge funds are holding shares in SHC
Sotera Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$18.60 (18.17% Upside)
$18.60 (18.17% Upside)
Blogger Sentiment
Bullish
SHC Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 210.3K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $485.6M over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
9.72%
12-Months-Change
Fundamentals
Return on Equity
10.86%
Trailing 12-Months
Asset Growth
1.19%
Trailing 12-Months
Company Description
Sotera Health Company
Sotera Health Company (SHC) is a leading provider of integrated sterilization and lab services, primarily serving the healthcare and pharmaceutical industries. The company operates through its key divisions, including sterilization services, laboratory services, and radiation services, offering critical solutions to ensure the safety and efficacy of medical devices and pharmaceuticals. SHC's portfolio includes a range of services such as ethylene oxide sterilization, gamma irradiation, and other sterilization technologies, catering to a diverse client base that includes manufacturers and healthcare providers.
SHC Company Deck
SHC Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
Sotera Health's earnings call highlighted strong financial performance, particularly in revenue growth and debt reduction, alongside significant achievements like Nordion's license renewal. However, challenges remain with Nelson Labs' revenue decline and ongoing litigation in Georgia.View all SHC earnings summariesSHC Stock 12 Month Forecast
Average Price Target
$18.60
▲(18.17% Upside)
Technical Analysis
Ownership Overview
Currently, No data available
---